Company / Free Cash Flow per Share
Eloxx Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.26
FY2016
5-year range
-$1.93 / -$0.26
FY2014-FY2016
Trend
+7.9%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-1.93 to $-0.26 over the past 2 years.
Based on SEC 10-K filings.
-0.26 in FY2016.
Improved from $-1.93 to $-0.26 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, free cash flow per share increased 7.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2016 | -$0.26 | +7.9% |
| FY2015 | -$0.28 | +85.4% |
| FY2014 | -$1.93 | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026